Abstract
Oxyprenylated natural products (isopentenyloxy-, geranyloxy- and the less spread farnesyloxy- compounds and their biosynthetic derivatives) represent a family of secondary metabolites that have been considered for years just as biosynthetic intermediates of the most naturally widespread C-prenylated derivatives. Only in the last decade have these natural products been recognized as interesting and valuable biologically active phytochemicals. Up to now about 300 molecules were isolated from plants mainly belonging to the families of Rutaceae, Apiaceae, and Compositae, comprising common edible vegetables and fruits. A wide variety of compounds containing a prenyloxy side chain has been isolated and among these coumarins, cinnamic acids and aromatic ketones displayed the most efficient and promising biological activities as anti-inflammatory agents. The aim of this review is to examine in detail the anti-inflammatory properties of these novel class of natural products.
Keywords: Anti-inflammatory activity, prenyloxycoumarins, prenyloxycinnamic acids, rutaceae
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Prenyloxyphenylpropanoids as a Novel Class of Anti-inflammatory Agents
Volume: 9 Issue: 2
Author(s): Salvatore Genovese, Massimo Curini and Francesco Epifano
Affiliation:
Keywords: Anti-inflammatory activity, prenyloxycoumarins, prenyloxycinnamic acids, rutaceae
Abstract: Oxyprenylated natural products (isopentenyloxy-, geranyloxy- and the less spread farnesyloxy- compounds and their biosynthetic derivatives) represent a family of secondary metabolites that have been considered for years just as biosynthetic intermediates of the most naturally widespread C-prenylated derivatives. Only in the last decade have these natural products been recognized as interesting and valuable biologically active phytochemicals. Up to now about 300 molecules were isolated from plants mainly belonging to the families of Rutaceae, Apiaceae, and Compositae, comprising common edible vegetables and fruits. A wide variety of compounds containing a prenyloxy side chain has been isolated and among these coumarins, cinnamic acids and aromatic ketones displayed the most efficient and promising biological activities as anti-inflammatory agents. The aim of this review is to examine in detail the anti-inflammatory properties of these novel class of natural products.
Export Options
About this article
Cite this article as:
Genovese Salvatore, Curini Massimo and Epifano Francesco, Prenyloxyphenylpropanoids as a Novel Class of Anti-inflammatory Agents, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010; 9 (2) . https://dx.doi.org/10.2174/187152310791110616
DOI https://dx.doi.org/10.2174/187152310791110616 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis
Current Pharmaceutical Design Phosphotyrosine Phosphatases in Cancer Diagnostic and Treatment
Recent Patents on DNA & Gene Sequences Genetics of Cardiomyopathies: Novel Perspectives with Next Generation Sequencing
Current Pharmaceutical Design Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets Previously Apparently Undescribed Autosomal-Recessive Multiple Congenital Anomalies/ Mental Retardation (MCA/MR) Syndrome Comprising: Fronto-Nasal Dysplasia, Hypertelorism, Short Stature and Brachydactily
Current Pediatric Reviews Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity
Current Pharmaceutical Biotechnology Design Potential Selective Inhibitors for Treating Cancer by Targeting the Src Homology 2 (SH2) Domain-Containing Phosphatase 2 (Shp2) with Core Hopping Approach
Protein & Peptide Letters Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Protein Tyrosine Phosphatase SHP-2 as Drug Target
Mini-Reviews in Organic Chemistry Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
Reviews on Recent Clinical Trials Small Molecules in Stem Cell Research
Current Pharmaceutical Biotechnology Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling
Current Medicinal Chemistry Induced Pluripotent Stem Cells in Regenerative Medicine and Disease Modeling
Current Stem Cell Research & Therapy Cathinone Neurotoxicity (“The “3Ms”)
Current Neuropharmacology Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics Tetralogy of Fallot and Hypoplastic Left Heart Syndrome – Complex Clinical Phenotypes Meet Complex Genetic Networks
Current Genomics Feline Immunodeficiency Virus Model for Designing HIV/AIDS Vaccines
Current HIV Research